19:I[66739,["/_next/static/chunks/0.3dg.jzl0xwf.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA","/_next/static/chunks/0qxr~fpya2kw0.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA","/_next/static/chunks/12wfgjmhh21qu.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA","/_next/static/chunks/028~snn2srcd-.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA","/_next/static/chunks/079qbl7l5rd72.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA","/_next/static/chunks/0hi8o2xq05aig.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA"],"default"] 1b:I[38632,["/_next/static/chunks/0qqtp3r0h7kah.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA","/_next/static/chunks/0iukvycbd42rl.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA"],"IconMark"] 1a:T4c5,

What if we stopped trying to cure disease and started preventing it instead? In this episode, Eric Topol, founder and director of the Scripps Research Translational Institute and a cardiologist, scientist, and author, joins a16z general partner Vijay Pande to unpack the future of aging, prevention, and precision health—as explored in Eric's new book, Super Agers: An Evidence-Based Approach to Longevity.

Together, they discuss AI-driven risk prediction and next-gen immunotherapies — a roadmap for how we could eliminate age-related diseases before they begin. From the transformative potential of GLP-1 drugs to organ-specific aging clocks, this episode is about the innovations with the potential to expand healthspan, not just lifespan.

Learn more about a16z Bio+Health
Learn more about & Subscribe to Raising Health
Find a16z Bio+Health on LinkedIn
Find a16z Bio+Health on X

Superaging with Eric Topol

Raising Health

Superaging with Eric Topol